MM
Moreland Mary K
Chairman & CEO
C-suiteF
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Moreland Mary K, Chairman & CEO. Insider active across 1 company, notably Abbott Laboratories. In total, 15 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €165k. History available since 1 August 2021. The latest transaction was filed on 28 April 2026 (I). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Moreland Mary K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
5,314 shares@ US$94.410.0003% mcap11.2% of flowCommon shares without par valueSEC:0001783147-26-000009:0
4,630 shares@ US$116.2613.4% of flowCommon shares without par valueSEC:0001783147-26-000007:0
613 shares@ US$115.581.8% of flowCommon shares without par valueSEC:0001783147-26-000007:1
13,951 shares0Common shares without par valueSEC:0001783147-26-000002:0
5,598 shares@ US$135.8721.5% of flowCommon shares without par valueSEC:0001415889-25-006786:0
791 shares@ US$138.173.1% of flowCommon shares without par valueSEC:0001415889-25-006786:1
10,712 shares0Common shares without par valueSEC:0001415889-25-005897:0
5,862 shares@ US$120.0519.1% of flowCommon shares without par valueSEC:0001415889-24-006410:0
10,574 shares0Common shares without par valueSEC:0001415889-24-005105:0
5,926 shares@ US$99.7716.4% of flowCommon shares without par valueSEC:0001415889-23-003912:0
12,259 shares0Common shares without par valueSEC:0001415889-23-003057:0
1,245 shares@ US$108.843.9% of flowCommon shares without par valueSEC:0001415889-22-008158:0
4,112 shares@ US$122.4112.2% of flowCommon shares without par valueSEC:0001415889-22-002197:0
15,813 shares0Common shares without par valueSEC:0001415889-22-001742:0
1,245 shares@ US$120.983.4% of flowCommon shares without par valueSEC:0001415889-21-003773:0
About Moreland Mary K
Moreland Mary K is Président-Directeur Général and Executive Vice President at Abbott Laboratories. She has 15 filings in total, and in the sampled recent filings, sales total 165199 EUR, with no purchases, over the period from 2021-08-03 to 2026-04-29. The most frequent transaction nature is Retenue fiscale.